166 related articles for article (PubMed ID: 23261466)
1. Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability.
Mishra VK; Palgunachari MN; McPherson DT; Anantharamaiah GM
Biochem Biophys Res Commun; 2013 Jan; 430(3):975-80. PubMed ID: 23261466
[TBL] [Abstract][Full Text] [Related]
2. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
[TBL] [Abstract][Full Text] [Related]
3. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
4. The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.
White CR; Datta G; Wilson L; Palgunachari MN; Anantharamaiah GM
Chem Phys Lipids; 2019 Mar; 219():28-35. PubMed ID: 30707910
[TBL] [Abstract][Full Text] [Related]
5. Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction.
Gu X; Huang Y; Levison BS; Gerstenecker G; DiDonato AJ; Hazen LB; Lee J; Gogonea V; DiDonato JA; Hazen SL
J Biol Chem; 2016 Jan; 291(4):1890-1904. PubMed ID: 26567339
[TBL] [Abstract][Full Text] [Related]
6. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.
Gaidukov L; Tawfik DS
Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586
[TBL] [Abstract][Full Text] [Related]
7. Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly.
Patel H; Ding B; Ernst K; Shen L; Yuan W; Tang J; Drake LR; Kang J; Li Y; Chen Z; Schwendeman A
Int J Nanomedicine; 2019; 14():3069-3086. PubMed ID: 31118623
[No Abstract] [Full Text] [Related]
8. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.
Wool GD; Reardon CA; Getz GS
J Lipid Res; 2008 Jun; 49(6):1268-83. PubMed ID: 18323574
[TBL] [Abstract][Full Text] [Related]
9. The effect of HDL mimetic peptide 4F on PON1.
Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
[TBL] [Abstract][Full Text] [Related]
10. Formation of stable nanodiscs by bihelical apolipoprotein A-I mimetic peptide.
Kariyazono H; Nadai R; Miyajima R; Takechi-Haraya Y; Baba T; Shigenaga A; Okuhira K; Otaka A; Saito H
J Pept Sci; 2016 Feb; 22(2):116-22. PubMed ID: 26780967
[TBL] [Abstract][Full Text] [Related]
11. The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles.
Sparks DL; Lund-Katz S; Phillips MC
J Biol Chem; 1992 Dec; 267(36):25839-47. PubMed ID: 1464598
[TBL] [Abstract][Full Text] [Related]
12. Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity.
Oda MN; Bielicki JK; Berger T; Forte TM
Biochemistry; 2001 Feb; 40(6):1710-8. PubMed ID: 11327831
[TBL] [Abstract][Full Text] [Related]
13. Effect of leucine to phenylalanine substitution on the nonpolar face of a class A amphipathic helical peptide on its interaction with lipid: high resolution solution NMR studies of 4F-dimyristoylphosphatidylcholine discoidal complex.
Mishra VK; Palgunachari MN; Krishna R; Glushka J; Segrest JP; Anantharamaiah GM
J Biol Chem; 2008 Dec; 283(49):34393-402. PubMed ID: 18845546
[TBL] [Abstract][Full Text] [Related]
14. Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides.
Nayyar G; Mishra VK; Handattu SP; Palgunachari MN; Shin R; McPherson DT; Deivanayagam CCS; Garber DW; Segrest JP; Anantharamaiah GM
J Lipid Res; 2012 May; 53(5):849-858. PubMed ID: 22377531
[TBL] [Abstract][Full Text] [Related]
15. Human carotid plaque phosphatidylcholine specifically interacts with paraoxonase 1, increases its activity, and enhances its uptake by macrophage at the expense of its binding to HDL.
Cohen E; Aviram M; Khatib S; Artoul F; Rabin A; Mannheim D; Karmeli R; Salamon T; Vaya J
Free Radic Biol Med; 2014 Nov; 76():14-24. PubMed ID: 25091896
[TBL] [Abstract][Full Text] [Related]
16. Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies.
Efrat M; Rosenblat M; Mahmood S; Vaya J; Aviram M
Atherosclerosis; 2009 Feb; 202(2):461-9. PubMed ID: 18585720
[TBL] [Abstract][Full Text] [Related]
17. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation, intestine, and paraoxonase-1.
Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
[TBL] [Abstract][Full Text] [Related]
19. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.
Sorenson RC; Bisgaier CL; Aviram M; Hsu C; Billecke S; La Du BN
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2214-25. PubMed ID: 10479665
[TBL] [Abstract][Full Text] [Related]
20. The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function.
James RW; Deakin SP
Adv Exp Med Biol; 2010; 660():173-81. PubMed ID: 20221880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
